Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling

As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S. in alignment with Trump’s Most Favored Nation policy, patients will suffer.